• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原代大鼠肝细胞培养中P-糖蛋白基因的差异表达

Differential expression of P-glycoprotein genes in primary rat hepatocyte culture.

作者信息

Lee C H, Bradley G, Zhang J T, Ling V

机构信息

Ontario Cancer Institute, Toronto, Canada.

出版信息

J Cell Physiol. 1993 Nov;157(2):392-402. doi: 10.1002/jcp.1041570223.

DOI:10.1002/jcp.1041570223
PMID:7901227
Abstract

The multidrug resistance (MDR)-associated protein, P-glycoprotein (Pgp), is expressed on the bile canalicular surface of hepatocytes, where it is thought to function in the detoxification of xenobiotics or in the transport of specific metabolites. Several studies have shown that Pgp expression in rat liver can be perturbed in vivo and in vitro; however, it is not known which of the 3 Pgp genes (class I, II, or III) are involved. In rodents, the class I and II Pgp genes have been shown to mediate MDR while the class III gene apparently does not. In this report, we have used gene-specific probes generated from the 3'-untranslated regions of the three rat Pgp genes (Deuchars et al.: Biochim. Biophys. Acta, 1130:157-165, 1992) to investigate Pgp gene expression in primary rat hepatocytes. We observed that the class II Pgp mRNA, the least abundant in the intact liver, is dramatically increased in culture over a 48 h period, while the class I Pgp showed only a modest increase in mRNA level. In contrast, the class III Pgp mRNA, which is the most abundant in the intact liver, exhibited a gradual decline. In rat liver hepatocytes, different culture conditions, as well as drugs such as cytochalasin D and colchicine, appear to affect the level of the class II Pgp gene expression. Moreover, under all these conditions, there is a strong correlation between the level of the class II Pgp and cytoskeletal (actin and tubulin) mRNAs. Thus, there may be a common mechanism regulating the expression of cytoskeletal protein genes and the class II Pgp gene. These findings have implications for our understanding of the regulation of Pgp gene expression in normal and malignant tissues.

摘要

多药耐药(MDR)相关蛋白P-糖蛋白(Pgp)表达于肝细胞的胆小管表面,人们认为它在异生物的解毒或特定代谢物的转运中发挥作用。多项研究表明,大鼠肝脏中的Pgp表达在体内和体外均可受到干扰;然而,尚不清楚3个Pgp基因(I类、II类或III类)中的哪一个参与其中。在啮齿动物中,I类和II类Pgp基因已被证明可介导MDR,而III类基因显然不能。在本报告中,我们使用了从3个大鼠Pgp基因的3'非翻译区生成的基因特异性探针(Deuchars等人:《生物化学与生物物理学报》,1130:157 - 165,1992)来研究原代大鼠肝细胞中的Pgp基因表达。我们观察到,II类Pgp mRNA在完整肝脏中含量最少,在培养48小时内显著增加,而I类Pgp的mRNA水平仅适度增加。相反,在完整肝脏中含量最丰富的III类Pgp mRNA则逐渐下降。在大鼠肝脏肝细胞中,不同的培养条件以及诸如细胞松弛素D和秋水仙碱等药物似乎会影响II类Pgp基因的表达水平。此外,在所有这些条件下,II类Pgp水平与细胞骨架(肌动蛋白和微管蛋白)mRNA水平之间存在很强的相关性。因此,可能存在一种共同机制来调节细胞骨架蛋白基因和II类Pgp基因的表达。这些发现对于我们理解正常组织和恶性组织中Pgp基因表达的调控具有重要意义。

相似文献

1
Differential expression of P-glycoprotein genes in primary rat hepatocyte culture.原代大鼠肝细胞培养中P-糖蛋白基因的差异表达
J Cell Physiol. 1993 Nov;157(2):392-402. doi: 10.1002/jcp.1041570223.
2
Overexpression of the class II P-glycoprotein gene in primary rat hepatocyte culture: evidence for increased mRNA stability.原代大鼠肝细胞培养中II类P-糖蛋白基因的过表达:mRNA稳定性增加的证据。
Cell Growth Differ. 1995 Mar;6(3):347-54.
3
Differential regulation of P-glycoprotein genes in primary rat hepatocytes by collagen sandwich and drugs.胶原蛋白夹心培养法和药物对原代大鼠肝细胞中P-糖蛋白基因的差异调节
J Cell Biochem. 2002;86(1):12-20. doi: 10.1002/jcb.10207.
4
Increased P-glycoprotein messenger RNA stability in rat liver tumors in vivo.体内大鼠肝肿瘤中P-糖蛋白信使核糖核酸稳定性增加。
J Cell Physiol. 1998 Oct;177(1):1-12. doi: 10.1002/(SICI)1097-4652(199810)177:1<1::AID-JCP1>3.0.CO;2-R.
5
Regulation of the multidrug resistance gene in regenerating rat liver.
Cell Growth Differ. 1990 Feb;1(2):57-62.
6
Extracellular matrix regulation of multidrug resistance in primary monolayer cultures of adult rat hepatocytes.成年大鼠肝细胞原代单层培养中细胞外基质对多药耐药性的调控
Cell Growth Differ. 1993 Jan;4(1):31-40.
7
Induction of multidrug resistance gene expression during cholestasis in rats and nonhuman primates.大鼠和非人灵长类动物胆汁淤积期间多药耐药基因表达的诱导
Hepatology. 1993 May;17(5):854-60.
8
Identification of in vivo P-glycoprotein mRNA decay intermediates in normal liver but not in liver tumors.在正常肝脏而非肝肿瘤中鉴定体内P-糖蛋白mRNA衰变中间体。
J Cell Physiol. 2005 Aug;204(2):638-45. doi: 10.1002/jcp.20313.
9
Induction of mdr1b mRNA and P-glycoprotein expression by tumor necrosis factor alpha in primary rat hepatocyte cultures.肿瘤坏死因子α在原代大鼠肝细胞培养物中诱导mdr1b信使核糖核酸和P-糖蛋白表达
J Cell Physiol. 1998 Sep;176(3):506-15. doi: 10.1002/(SICI)1097-4652(199809)176:3<506::AID-JCP7>3.0.CO;2-S.
10
Divergent regulation of the class II P-glycoprotein gene in primary cultures of hepatocytes versus H35 hepatoma by glucocorticoids.糖皮质激素对原代培养肝细胞与H35肝癌细胞中II类P-糖蛋白基因的不同调控作用。
Cell Growth Differ. 1995 Oct;6(10):1321-32.

引用本文的文献

1
Regulation of P-Glycoprotein during Oxidative Stress.氧化应激期间P-糖蛋白的调节
Antioxidants (Basel). 2024 Feb 8;13(2):215. doi: 10.3390/antiox13020215.
2
Models and methods for in vitro testing of hepatic gap junctional communication.肝间隙连接通讯的体外测试模型与方法
Toxicol In Vitro. 2015 Dec 25;30(1 Pt B):569-577. doi: 10.1016/j.tiv.2015.09.024. Epub 2015 Sep 28.
3
P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: A review.天然来源的 P-糖蛋白抑制剂作为潜在的肿瘤化疗增敏剂:综述。
J Adv Res. 2015 Jan;6(1):45-62. doi: 10.1016/j.jare.2014.11.008. Epub 2014 Dec 1.
4
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.近年来,利用原代肝细胞、替代的肝细胞来源和非实质细胞的 2D 和 3D 体外系统在研究肝毒性、细胞信号转导和 ADME 的机制方面取得了进展。
Arch Toxicol. 2013 Aug;87(8):1315-530. doi: 10.1007/s00204-013-1078-5. Epub 2013 Aug 23.
5
Differential expression of ABC transporters (MDR1, MRP1, BCRP) in developing human embryos.ABC 转运蛋白(MDR1、MRP1、BCRP)在人胚胎发育中的差异表达。
J Mol Histol. 2011 Dec;42(6):567-74. doi: 10.1007/s10735-011-9363-1. Epub 2011 Oct 20.
6
Minimizing liver uptake of cationic Tc radiotracers with ether and crown ether functional groups.利用具有醚和冠醚官能团的物质使阳离子锝放射性示踪剂的肝脏摄取量最小化。
World J Hepatol. 2010 Jan 27;2(1):21-31. doi: 10.4254/wjh.v2.i1.21.
7
Evaluation of (99)  (m)TcN-MPO as a new myocardial perfusion imaging agent in normal dogs and in an acute myocardial infarction canine model: comparison with (99)  (m)Tc-sestamibi.评价新型心肌灌注显像剂 99mTcN-MPO 在正常犬和急性心肌梗死犬模型中的应用:与 99mTc-sestamibi 的比较。
Mol Imaging Biol. 2011 Feb;13(1):121-7. doi: 10.1007/s11307-010-0304-2.
8
Mechanism for myocardial localization and rapid liver clearance of Tc-99m-N-MPO: a new perfusion radiotracer for heart imaging.Tc-99m-N-MPO心肌定位及肝脏快速清除机制:一种用于心脏成像的新型灌注放射性示踪剂
J Nucl Cardiol. 2009 Jul-Aug;16(4):571-9. doi: 10.1007/s12350-009-9068-y. Epub 2009 Mar 14.
9
Evaluation of (64)Cu(DO3A-xy-TPEP) as a potential PET radiotracer for monitoring tumor multidrug resistance.评估(64)Cu(DO3A-xy-TPEP)作为监测肿瘤多药耐药性的潜在正电子发射断层显像(PET)放射性示踪剂。
Bioconjug Chem. 2009 Apr;20(4):790-8. doi: 10.1021/bc800545e.
10
Tc-99m-N-MPO: novel cationic Tc-99m radiotracer for myocardial perfusion imaging.锝-99m-N-甲基吡咯戊二酮:用于心肌灌注显像的新型阳离子锝-99m放射性示踪剂。
J Nucl Cardiol. 2008 Jul-Aug;15(4):535-46. doi: 10.1016/j.nuclcard.2008.02.022. Epub 2008 Apr 21.